Welcome page

What's New

CNI William McK. and Marcia N. Thompson Center for Restorative Neurosurgery at CNI
701 East Hampden Ave.
Suite 330
Englewood, CO 80113
(303) 788-4010
(303) 788-8854 fax

What's New

Also see News at the CNI Movement Disorders Center

CNI Parkinson Press Newsletter

Summer 2007 Dementia is described as advanced cognitive deficits that impair normal functioning such as when memory problems start to interfere with basic daily activities. It is a process whereas the individual becomes progressively confused. The earliest signs are usually memory problems, changes in their way of speaking, such as forgetting words, and personality problems. The person may have difficulty with problem solving, learning new skills and impaired decision making.

Spring 2007 The FDA is notifying you that the companies that manufacture and distribute pergolide have agreed to withdraw this drug from the market due to the potential for heart valve damage. Two new studies showed that patients with Parkinson’s disease who were treated with pergolide had an increased chance of serious damage to their heart valves when compared to patients who did not receive the drug. Pergolide is a member of a class of drugs known as dopamine agonists and is used with levodopa and carbidopa to manage the signs and symptoms (tremors and slowness of movement) of Parkinson’s disease.

You will need Acrobat Reader to view PDF files. Get Acrobat Reader.

For back issues of the CNI Parkinson Press Newsletters,  please visit our Archive page.

Movement Disorders Focus of CNI REVIEW Journal

The Fall 2005 issue of CNI's medical journal, CNI REVIEW, is dedicated to discussing the issues related to movement disorders.
Read entire issue online now.

Included in this issue of CNI REVIEW is the following article:

Surgical Treatment of Movement Disorders
Steven G. Ojemann, M.D.

The surgical treatment of movement disorders has evolved considerably over the last decade in terms of the scope of the indications for surgery, and in terms of technique. Deep Brain Stimulation (DBS) has an established role in the treatment of Parkinson's disease and essential tremor. As a surgical procedure, it offers inherent advantages over ablative therapies, as the therapeutic and side effects of stimulation can be modulated by adjustment of multiple stimulation parameters. DBS is finding increasing application for the treatment of dystonias, and for tremor disorders other than essential tremor. These conditions, many of which are notoriously difficult to treat medically, are reviewed in this article. The objective is to focus on the conditions for which surgical treatments may be beneficial, the indications and contraindications to these procedures, and on the surgical techniques and outcomes.

How You Can Help

The Colorado Neurological Institute’s mission is to provide the highest quality, most advanced and comprehensive care to patients with neurological disease and to offer hope to those who suffer. CNI is a non-profit organization. Your tax deductible contributions can help us reach more people who need hope. Find out how you can help. Call our development office: Melissa Francis at (303) 806-7415. Make a donation online.

Colorado Neurological Institute's William McK. and Marcia N. Thompson Center for Restorative Neurosurgery
701 East Hampden Ave., Suite 330, Englewood, CO 80113
Phone: (303) 788-4600, Fax: (303) 788-8854, Email Us

The medical information presented on this website is meant for general educational purposes only.
Persons should consult their physician regarding specific medical concerns or treatment. Copyright 2007, Colorado Neurological Institute.
 

Email  to
website editor